Company Overview of Ardent Pharmaceuticals, Inc.
Ardent Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of delta receptor compounds. It develops a range of drugs for use in moderate to severe pain, urinary incontinence, premature ejaculation, depression, cardioprotection, glaucoma, neuroprotection, immunomodulation, and drug abuse. The company’s DPI-3290 IV formulation is used for acute pain. Ardent Pharmaceuticals, Inc. was formerly known as Delta Pharmaceuticals, Inc. The company is based in Durham, North Carolina. As of 12/20/2004, Ardent Pharmaceuticals, Inc. is a subsidiary of Enhance Biotech, Inc.
631 United Drive
Durham, NC 27713
Key Executives for Ardent Pharmaceuticals, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Ardent Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.